Zacks7d agobearish
TransMedics Stock Dips Post Q2 Earnings Miss, Margins ContractTMDX's Q2 revenue beat and raised outlook are overshadowed by earnings miss, declining margins and sharply higher operating costs.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
309last 24h
2116last 7d
376● bullish (7d)
181● bearish (7d)
204publishers
Motley Fool49d agobearish
What a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock DropSpecializing in organ preservation technology, this medical device innovator reported a notable insider sale amid ongoing sector challenges.
Zacks98d agobearish
TMDX Dips After Posting Q1 Earnings & Revenue Miss, Margins FallTransMedics' Q1 revenues rise 21% on strong OCS demand, but a sharp EPS miss and margin pressure send shares down despite continued logistics growth.
Zacks99d agobearish
TransMedics (TMDX) Q1 Earnings and Revenues Miss EstimatesTransMedics (TMDX) delivered earnings and revenue surprises of -51.46% and -0.99%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?